Vraylar 6 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM1GS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,741
Award facts
- Contract value 100% obligated
- $13,740.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,740.59 to AmerisourceBergen Drug Corp for the supply of Vraylar 6 mg capsules (quantity: 30-count packages). This is a firm fixed price delivery order with no set-aside designation, issued on December 28, 2025, with an ultimate completion date of December 29, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Vraylar is a brand-name antipsychotic medication used in the treatment of neurological and psychiatric conditions, reflecting the range of specialty pharmaceuticals that AmerisourceBergen supplies to federal military and veteran healthcare systems through its prime vendor agreement. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to fulfill federal procurement requirements through competitive award processes across multiple therapeutic domains, including psychiatric medications, diabetes treatments, pain management drugs, and medical supplies. The DLA Troop Support Medical contract enables the company to supply critical pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems supporting military operations and personnel worldwide.
Quick answers
Who was awarded contract SPE2DR26FM1GS?
SPE2DR26FM1GS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 28, 2025.
How much is contract SPE2DR26FM1GS worth?
The government has obligated $13,741 on SPE2DR26FM1GS.
Is contract SPE2DR26FM1GS an order under another contract?
Yes. SPE2DR26FM1GS is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1GS competed?
The extent of competition for SPE2DR26FM1GS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award